hrcak mascot   Srce   HID

Stručni rad

WHICH TUBERCULIN SKIN TEST HYPERREACTIVE CHILD SHOULD BE TREATED WITH – OUR EXPERIENCE

Ivan Pavić
Iva Hojsak
Ljiljana Žmak
Dorian Tješić-Drinković
Jasna Čepin Bogović
Vera Katalinić-Janković

Puni tekst: hrvatski, pdf (496 KB) str. 0-0 preuzimanja: 136* citiraj
APA 6th Edition
Pavić, I., Hojsak, I., Žmak, Lj., Tješić-Drinković, D., Čepin Bogović, J. i Katalinić-Janković, V. (2015). KOJIM PPD-HIPERREAKTORIMA TREBA DATI PROFILAKSU – NAŠA ISKUSTVA. Liječnički vjesnik, 137 (7-8), 0-0. Preuzeto s https://hrcak.srce.hr/172715
MLA 8th Edition
Pavić, Ivan, et al. "KOJIM PPD-HIPERREAKTORIMA TREBA DATI PROFILAKSU – NAŠA ISKUSTVA." Liječnički vjesnik, vol. 137, br. 7-8, 2015, str. 0-0. https://hrcak.srce.hr/172715. Citirano 20.10.2019.
Chicago 17th Edition
Pavić, Ivan, Iva Hojsak, Ljiljana Žmak, Dorian Tješić-Drinković, Jasna Čepin Bogović i Vera Katalinić-Janković. "KOJIM PPD-HIPERREAKTORIMA TREBA DATI PROFILAKSU – NAŠA ISKUSTVA." Liječnički vjesnik 137, br. 7-8 (2015): 0-0. https://hrcak.srce.hr/172715
Harvard
Pavić, I., et al. (2015). 'KOJIM PPD-HIPERREAKTORIMA TREBA DATI PROFILAKSU – NAŠA ISKUSTVA', Liječnički vjesnik, 137(7-8), str. 0-0. Preuzeto s: https://hrcak.srce.hr/172715 (Datum pristupa: 20.10.2019.)
Vancouver
Pavić I, Hojsak I, Žmak Lj, Tješić-Drinković D, Čepin Bogović J, Katalinić-Janković V. KOJIM PPD-HIPERREAKTORIMA TREBA DATI PROFILAKSU – NAŠA ISKUSTVA. Liječnički vjesnik [Internet]. 2015 [pristupljeno 20.10.2019.];137(7-8):0-0. Dostupno na: https://hrcak.srce.hr/172715
IEEE
I. Pavić, I. Hojsak, Lj. Žmak, D. Tješić-Drinković, J. Čepin Bogović i V. Katalinić-Janković, "KOJIM PPD-HIPERREAKTORIMA TREBA DATI PROFILAKSU – NAŠA ISKUSTVA", Liječnički vjesnik, vol.137, br. 7-8, str. 0-0, 2015. [Online]. Dostupno na: https://hrcak.srce.hr/172715. [Citirano: 20.10.2019.]

Sažetak
Since persons with latent tuberculosis infection (LTBI) represent a huge reservoir of potential tuberculosis (TB) disease, accurate diagnosis and treatment of LTBI is essential for TB control and eradication. The aim was to assess the diagnostic value of determination of interferon-gamma release assay in school children with hyperreactive tuberculin skin test (TST) reaction. A total of 120 BCG-vaccinated children were investigated due to a hyperreactive TST results. The QuantiFERON-TB Gold In-Tube test (QFT-GIT) was performed. Fifteen children (12.5%) had positive QFT-GIT and 105 (87.5%) children had negative QFT-GIT. There was no statistically significant difference in TST reaction (21.5 mm u QFT+ vs. 20.9 mm u QFT- group, p=0.458). The children with positive QFT-GIT had a statistically higher level of interferon-gamma (IFN-g) than children with negative QFT-GIT. There were no statistically significant differences in concentrations of IFN-g either basic or upon stimulation with mitogen phytohemagglutinin. After isoniazid prophylaxis QFT-GIT remained positive in two children (p=0.019). In a difficult procedure for diagnosing LTBI in BCG-vaccinated children determination of IFN-g could be the key factor in making decision whether to use preventive therapy or not.

Ključne riječi
Latent tuberculosis – diagnosis, drug therapy; Tuberculin test; Interferon-gamma release tests; Antitubercular agents – therapeutic use; Rifampin – therapeutic use; Isoniazid – therapeutic use

Hrčak ID: 172715

URI
https://hrcak.srce.hr/172715

[hrvatski]

Posjeta: 242 *